Protect Pharmaceutical Corporation
PRTT
$0.19
-$0.02-9.52%
OTC PK
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.10K | 100.00 | -- | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 20.10K | 100.00 | -- | -- | -- |
|
|
|||||
| Total Current Assets | 20.10K | 100.00 | -- | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 20.10K | 100.00 | -- | -- | -- |
|
|
|||||
| Total Accounts Payable | 1.20K | 1.00K | 1.00K | 1.00K | 1.00K |
| Total Accrued Expenses | 13.70K | 9.90K | 6.20K | 2.50K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 35.80K | 35.40K | 35.30K | 35.30K | 35.30K |
| Total Other Current Liabilities | 35.80K | 35.40K | 35.30K | 35.30K | 35.30K |
| Total Current Liabilities | 50.70K | 46.30K | 42.40K | 38.70K | 36.20K |
|
|
|||||
| Total Current Liabilities | 50.70K | 46.30K | 42.40K | 38.70K | 36.20K |
| Long-Term Debt | 121.00K | 101.00K | 101.00K | 100.80K | 100.30K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 171.70K | 147.30K | 143.40K | 139.50K | 136.60K |
|
|
|||||
| Common Stock & APIC | 9.37M | 9.37M | 9.37M | 9.37M | 9.37M |
| Retained Earnings | -9.52M | -9.52M | -9.51M | -9.51M | -9.51M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -151.60K | -147.20K | -143.40K | -139.50K | -136.60K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -151.60K | -147.20K | -143.40K | -139.50K | -136.60K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -151.60K | -147.20K | -143.40K | -139.50K | -136.60K |
|
|
|||||